Answers are grounded in this paper and cite their sources.
, we show in the EC mouse model that a combination of NP137 with carboplatin-paclitaxel outperformed carboplatin-paclitaxel alone. Our results identify netrin-1 blockade as a clinical strategy triggering both tumour debulking and EMT inhibition, thus potentially alleviating resistance to standard treatments.
No takes yet. Share an insight, caveat, or question.
Cassier et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: